Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS-801 phase 3 comparative study
jRCT2080220025Phase 3
- Sponsor
- Sankyo Co.,Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of imidafenacin in overactive bladder (OAB), urge incontinence and frequent urination, sponsored by Sankyo Co.,Ltd.
02
Drugs
imidafenacin
03
Conditions
overactive bladder (OAB)urge incontinencefrequent urination
Beyond the preview
Go deeper on jRCT2080220025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220025.